Aprogen is a startup based in South Korea, most recent round Series-c-plus, 1 tracked investor.
Aprogen is a startup founded in 2000 based in South Korea. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Aprogen is a biotechnology company specializing in the development of novel antibody therapeutics and biosimilars.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.